MarketBeat
21 Sept 2026, 02:02 UTC · 2h ago
Verdict
Headline takes no side. We score NEO +0.80 across four claims — strongly bullish.
+0.80strongly bullish
More positive than 83% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish · 0 new · 4 priced in
NeoGenomics' RaDaR ST MRD test coverage for immuno-oncology applications expands its addressable market by approximately $4 billion.
Priced indiscussion of existing coverage at conference
So whatThis represents a 20% capture of the total $20 billion MRD market opportunity.
More positive than 92% of claims this week
The company expects liquid biopsy (PanTracer LBx) to become a substantial contributor in late 2027 and 2028.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Priced inconference presentation of future outlook
So whatThis timeline suggests liquid biopsy will not materially impact EPS or revenue growth for the next 24 months.
More positive than 76% of claims this week
NGS revenue grew 26% in H1 2026, with about half of that growth driven by revenue-cycle-management (RCM) and a shift toward larger panels.
Priced inanalysis of H1 2026 results
So whatThe 13% RCM-driven growth component implies revenue expansion is partially decoupling from pure patient volume.
More positive than 62% of claims this week
NeoGenomics is targeting positive free cash flow for the full year, despite a DOJ settlement payment in Q3.
Priced inCFO remarks at conference
So whatAchieving this goal would eliminate the need for further equity dilution to fund the mentioned IT and R&D investments.
More positive than 49% of claims this week
Which stocks this story touches
More positive than 83% of ticker scores this week
The company is reporting strong NGS growth, expanding its addressable market via new test coverage, and implementing efficiency-driving billing systems.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
24/7 Wall Street
3d ago
—
NEO hasn't traded since this ran. Last close $19.91 (Sep 18); the reaction starts at the next open.
NEO chart →
